Met Life Investment Management, LLC Alkermes Plc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 93,203 shares of ALKS stock, worth $2.62 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
93,203
Previous 97,201
4.11%
Holding current value
$2.62 Million
Previous $2.34 Million
11.36%
% of portfolio
0.02%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding ALKS
# of Institutions
364Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$817 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$533 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$365 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$355 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$258 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.61B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...